Skip to content

Clinical trials

Completed Hypertension, Pulmonary trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypertension, Pulmonary Status: Completed Country / region: United States Clear all

180 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20025
20033
20046
20059
200611
20075
200810
200920
201011
201114
201212
201310
20149
20156
20167
201711
20184
20198
20203
20214
20222
20235

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed180

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
United Therapeutics17
National Heart, Lung, and Blood Institute (NHLBI)9
Bayer8
Actelion6
GlaxoSmithKline5
Stanford University5
University of Pennsylvania5
Gilead Sciences4
Mayo Clinic4
The Cleveland Clinic4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypertension, Pulmonary180
Pulmonary Arterial Hypertension46
Anemia, Sickle Cell13
Heart Failure13
Lung Diseases, Interstitial9
Hypertension7
Pulmonary Disease, Chronic Obstructive7
Pulmonary Fibrosis7
Familial Primary Pulmonary Hypertension5
Idiopathic Pulmonary Fibrosis5

Trials

Showing 1 to 25 of 180. Each trial links to its page on Pharma Observatory.

80 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.